tiprankstipranks
Trending News
More News >

Shionogi Amends Tender Offer for Torii Amid Patent Lawsuit

Story Highlights
Shionogi Amends Tender Offer for Torii Amid Patent Lawsuit

Confident Investing Starts Here:

The latest update is out from Shionogi & Co ( (JP:4507) ).

Shionogi & Co., Ltd. announced an amendment to its tender offer for shares of Torii Pharmaceutical Co., Ltd. due to a patent infringement lawsuit involving Torii’s oral antipruritus medication, REMITCH®. Despite the legal proceedings, Torii’s stance on the tender offer remains unchanged, as the financial implications of the lawsuit are still uncertain.

The most recent analyst rating on (JP:4507) stock is a Hold with a Yen2750.00 price target. To see the full list of analyst forecasts on Shionogi & Co stock, see the JP:4507 Stock Forecast page.

More about Shionogi & Co

Shionogi & Co., Ltd. is a pharmaceutical company based in Osaka, Japan, known for its development and production of prescription drugs. The company focuses on creating innovative treatments for various medical conditions, with a strong emphasis on research and development within the pharmaceutical industry.

Average Trading Volume: 2,649,160

Technical Sentiment Signal: Strong Buy

Current Market Cap: Yen2119.7B

For detailed information about 4507 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App